Plasma Protein Fraction (Human) (Plasmanate)
Plasma Protein Fraction (Human) is an FDA-licensed reference biologic from Grifols Therapeutics LLC. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
1958
Reference approved
Reference product
Plasmanate Plasma Protein Fraction (Human)
Grifols Therapeutics LLC
- Approved
- Oct 02, 1958
- Marketing
- Rx
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for Plasma Protein Fraction (Human), in chronological order.
Reference approval
Approval date of the reference Plasma Protein Fraction (Human) product.
68 yr 8 mo ago
Frequently asked questions
Are there biosimilars approved for Plasma Protein Fraction (Human) (Plasmanate)?
No 351(k) biosimilars or interchangeable biosimilars referencing Plasma Protein Fraction (Human) are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.